The Role of Partial Laryngectomy Among Organ Preservation Strategies in T3 Laryngeal Cancer
09-10, 16:30–17:00 (Europe/Istanbul), Head & Neck Oncology 3

<p>Description: This presentation will explore the evolving role of partial laryngectomy in the treatment of T3 laryngeal cancer within the framework of contemporary organ preservation strategies. While concurrent chemoradiotherapy has become the preferred modality for many patients, particularly in an effort to preserve laryngeal function, surgical options such as partial laryngectomy remain highly relevant in selected cases. Through clinical evidence and case-based discussion, this session will highlight the indications, technical considerations, and outcomes of partial laryngectomy in the modern era.</p> <p>Outcome Objectives: Understand the rationale behind organ preservation strategies in T3 laryngeal cancer and their current place in treatment guidelines. Identify the clinical and anatomical criteria that make a patient a candidate for partial laryngectomy. Compare the oncological and functional outcomes of partial laryngectomy versus non-surgical approaches such as chemoradiotherapy. Integrate multidisciplinary perspectives when evaluating treatment options for advanced laryngeal cancer.</p> <p>Background: The management of T3 laryngeal cancer has significantly evolved over the past two decades, with a marked shift toward organ-preserving chemoradiotherapy protocols. While these approaches can successfully maintain the anatomical integrity of the larynx, they do not always guarantee preservation of its function and may be associated with long-term toxicity. In selected patients, partial laryngectomy offers an alternative that not only achieves local control but also provides favorable functional outcomes. However, the use of partial surgery has declined in clinical practice, often due to overgeneralization of non-surgical strategies. This presentation aims to revisit and recontextualize the role of partial laryngectomy in light of current evidence and patient-centered care considerations.</p>

<p>The aim of this presentation is to critically assess the role of partial laryngectomy as a viable organ- and function-preserving surgical option in the treatment of T3 laryngeal cancer. By reviewing current evidence, patient selection criteria, and multidisciplinary treatment planning, the session seeks to reestablish the relevance of partial laryngectomy in an era dominated by non-surgical organ preservation strategies such as chemoradiotherapy.</p>
Moderator-Speaker Moderator-Speaker
Speaker Speaker
<p>He was born in 1987 in Istanbul. He graduated from Hacettepe University Faculty of Medicine in 2012. He completed her specialty education in Istanbul University Cerrahpaşa Faculty of Medicine, Department of Otorhinolaryngology in 2017. He completed her compulsory service at Erzincan Binali Yıldırım University Mengücek Gazi Training and Research Hospital Otorhinolaryngology Clinic between 2017-2020. In 2020, He started working as a lecturer doctor in the Department of Otorhinolaryngology, Bursa Uludag University Faculty of Medicine, and he still continues to work. In 2017, he successfully passed the written and oral exams organized by the Turkish Otorhinolaryngology and Head and Neck Surgery Board and received the Certificate of Competence. In 2019, he worked as observer at the University of Texas MD Anderson Cancer Hospital in the United States for 1 month. He was awarded the title of Fellow of the European Board of ORL-HNS (FEBORL-HNS) by being successful in the written and oral exam he also entered in 2019.</p>
This speaker also appears in:
<p>Dr. Çağlar Eker, MD</p> <p>Date and Place of Birth: June 19, 1988 – Niğde, Turkey</p> <p>Email: [email protected] | Phone: +90 506 775 58 47</p> <p>Address: Adana, Turkey</p> <p>EDUCATION</p> <p>Otorhinolaryngology and Head & Neck Surgery Residency</p> <p>Cerrahpaşa Medical School, Istanbul University (2014–2018)</p> <p>Medical School</p> <p>Istanbul Faculty of Medicine, Istanbul University (Graduated: 2013)</p> <p>PROFESSIONAL EXPERIENCE</p> <p>Resident Physician</p> <p>Department of ENT and Head & Neck Surgery, Cerrahpaşa Medical School (2014–2018)</p> <p>ENT Specialist</p> <p>Islahiye State Hospital, Gaziantep (2018–2021)</p> <p>Assistant Professor</p> <p>Department of ENT and Head & Neck Surgery, Çukurova University Faculty of Medicine (2021–Present)</p> <p>LANGUAGES</p> <p>English: Advanced</p> <p>SELECTED PUBLICATIONS</p> <p>Eker Ç. et al. Clinical and Radiological Predictors of Oncological Outcomes in T1 Glottic Cancer. Eur Arch Otorhinolaryngol, 2024.</p> <p>Eker Ç, et al. Investigation of Post-Earthquake Dizziness After 2023 Türkiye Earthquakes: An Observational Case-Control Study. J Int Adv Otol. 2024</p> <p>Eker Ç. et al. TLR-2, -3, and -4 Gene Expressions in Laryngeal Squamous Cell Carcinoma. Turk Arch Otorhinolaryngol, 2022.</p> <p>Eker C, et al. Alternating pattern of rhino-orbital-cerebral mucormycosis with COVID-19 in diabetic patients. Eur Arch Otorhinolaryngol. 2023</p> <p>Eker Ç. et al. Predictive Models for Long-Term Hospitalization and Complications in Deep Neck Infections. ENT Updates, 2024.</p> <p>Over 10 publications in national and international peer-reviewed journals.</p> <p>CONFERENCE PRESENTATIONS</p> <p>Presented in numerous national and international congresses.</p> <p>Invited Speaker Topics:</p> <p>Orbital Exenteration (2022)</p> <p>Stapes Footplate Fistula (2022)</p> <p>Approach to Carotid Body Tumors (2023)</p> <p>Oral Cavity Reconstruction with Supraclavicular Island Flap (2023)</p> <p>CERTIFICATES</p> <p>European Board of Otorhinolaryngology, Head & Neck Surgery – Certificate of Proficiency, 2024</p> <p>Turkish Board of Otorhinolaryngology – Certificate of Proficiency, 2022</p> <p>Head & Neck and Thyroid Surgery School Certificate – Turkish ENT Society, 2022</p> <p>OBSERVERSHIP</p> <p>Netherlands Cancer Institute, Amsterdam (2024)</p> <p>Department of Head & Neck Surgery</p> <p>MEMBERSHIPS</p> <p>Turkish Society of Otorhinolaryngology – Head and Neck Surgery</p> <p>Çukurova Society of Otorhinolaryngology</p> <p>REFERENCES</p> <p>Prof. Dr. M. Mete Kıroğlu – Çukurova University, Faculty of Medicine</p> <p>Email: [email protected]</p> <p>Prof. Dr. H. Murat Yener – Cerrahpaşa Medical School, Istanbul University</p> <p>Email: [email protected]</p>
This speaker also appears in: